Cyteir Therapeutics OverviewCyteir Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CYT.
Quarterly EBIT
-$5.17M
↑ 56.03% YoY
As of Sep 30, 2023
Annual EBIT (TTM)
-$38.42M
↑ 23.34% YoY
Trailing 12 months ending Sep 30, 2023
Cyteir Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for CYT.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023